Alkosign IPO vs Fabino Life Sciences IPO

Comparison between Alkosign IPO and Fabino Life Sciences IPO.

IPO Details

Alkosign IPO is a SME Fixed Price IPO proposed to list at BSE SME while Fabino Life Sciences IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Alkosign IPO is up to ₹11.53 Cr whereas the issue size of the Fabino Life Sciences IPO is up to ₹3.07 Cr. The final issue price of Alkosign IPO is ₹45.00 per share and of Fabino Life Sciences IPO is ₹36.00 per share.

 Alkosign IPOFabino Life Sciences IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹45.00 per share₹36.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size3000 shares3000 shares
Fresh Issue Size25,62,000 shares8,52,000 shares
Fresh Issue Size (Amount)up to ₹11.53 Crup to ₹3.07 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total25,62,000 shares8,52,000 shares
Issue Size Total (Amount)up to ₹11.53 Crup to ₹3.07 Cr

IPO Timetable

Alkosign IPO opens on Jan 18, 2022, while Fabino Life Sciences IPO opens on Dec 31, 2021. The closing date of Alkosign IPO and Fabino Life Sciences IPO is Jan 21, 2022, and Jan 05, 2022, respectively.

 Alkosign IPOFabino Life Sciences IPO
Issue OpenJan 18, 2022Dec 31, 2021
Issue CloseJan 21, 2022Jan 05, 2022
Basis Of Allotment (Tentative)Jan 27, 2022Jan 10, 2022
Initiation of Refunds (Tentative)Jan 28, 2022Jan 11, 2022
Credit of Share (Tentative)Jan 28, 2022Jan 12, 2022
Listing date (Tentative)Feb 01, 2022Jan 13, 2022

Financials & KPIs

Alkosign IPO P/E ratio is , as compared to Fabino Life Sciences IPO P/E ratio of 133.

 Alkosign IPOFabino Life Sciences IPO
Financials

Company Financials (Restated)

Period Ended30 Nov 202131 Mar 2021
Assets22.7123.66
Total Income5.9213.28
Profit After Tax-0.640.66
EBITDA0.991.42
NET Worth2.400.67
Reserves and Surplus-0.350.66
Total Borrowing19.2620.47
Amount in ₹ Crore

Company Financials (Restated)

Period Ended30 Jun 202131 Mar 202131 Mar 202031 Mar 2019
Assets2.812.253.598.55
Total Income1.133.067.522.76
Profit After Tax0.010.030.070.00
EBITDA0.030.060.320.32
NET Worth1.321.300.670.60
Reserves and Surplus0.120.100.520.45
Total Borrowing0.420.311.082.52
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100%99.43%
Promoter Shareholding (Post-Issue)50.41%56.82%
P/E Ratio133
Market Cap₹24.50 Cr.₹7.56 Cr.
ROE197
ROCE13
Debt/Equity30.46
EPS₹10.86
RoNW98.51

Shares Offered

In the Alkosign IPO Retail Individual Investors (RII) are offered 12,81,000 shares while in Fabino Life Sciences IPO retail investors are offered 12,81,000 shares. Qualified Institutional Buyers (QIB) are offered in Alkosign IPO and in Fabino Life Sciences IPO.

 Alkosign IPOFabino Life Sciences IPO
Market Maker Reservation1,38,000 shares48,000 shares
NII12,81,000 shares4,26,000 shares
RII12,81,000 shares4,26,000 shares
Total25,62,000 shares8,52,000 shares

Bids Received (Subscription)

Alkosign IPO subscribed 4.76x in total, whereas Fabino Life Sciences IPO subscribed 6.93x.

 Alkosign IPOFabino Life Sciences IPO
NII (times)3.14x3.49x
RII (times)6.39x10.36x
Total (times)4.76x6.93x

Compare with others

Compare:

Alkosign IPO Vs Fabino Life Sciences IPO